Correlation Between Amylyx Pharmaceuticals and Mink Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Mink Therapeutics, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Mink Therapeutics.

Diversification Opportunities for Amylyx Pharmaceuticals and Mink Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Amylyx and Mink is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Mink Therapeutics go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Mink Therapeutics

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 2.1 times more return on investment than Mink Therapeutics. However, Amylyx Pharmaceuticals is 2.1 times more volatile than Mink Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  531.00  in Amylyx Pharmaceuticals on August 26, 2024 and sell it today you would lose (4.00) from holding Amylyx Pharmaceuticals or give up 0.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Amylyx Pharmaceuticals  vs.  Mink Therapeutics

 Performance 
       Timeline  
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Amylyx Pharmaceuticals and Mink Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amylyx Pharmaceuticals and Mink Therapeutics

The main advantage of trading using opposite Amylyx Pharmaceuticals and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.
The idea behind Amylyx Pharmaceuticals and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing